Finance

Lists
SLQT:NYSE
SelectQuote Inc
$0.50
-3.19%
(-0.017) 1D
Aug 31, 11:59:05 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLQT...
Open
$0.51
High
$0.54
Low
$0.49
Mkt. cap
88.89M
Avg. vol.
1.10M
Volume
1.91M
P/E ratio
4.96
52-wk high
$2.24
52-wk low
$0.48
EPS
$0.10
Beta
1.66
Shares outstanding
176.57M
No. of employees
4K
Open
$0.51
High
$0.54
Low
$0.49
Mkt. cap
88.89M
Avg. vol.
1.10M
Volume
1.91M
P/E ratio
4.96
52-wk high
$2.24
52-wk low
$0.48
EPS
$0.10
Beta
1.66
Shares outstanding
176.57M
No. of employees
4K
Profile
SelectQuote is a direct-to-consumer distribution platform for selling insurance policies and healthcare services. Their insurance business earns commissions by connecting consumers with insurance carriers that provide senior health, life, automobile, and home insurance. The healthcare services business mainly consists of SelectRx, an accredited pharmacy. The company went public on May 21, 2020. Wikipedia
About SelectQuote Inc
CEOTim Danker
Employees4.27K
Founded1985
HeadquartersOverland Park, Kansas, United States
SectorInsurance
Analyst ratings
Based on 3 analysts giving stock ratings to SLQT in the past 3 months
Buy
Buy
1
Hold
2
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SLQT in the last 3 months.
Highest
Current $0.50
$3.00 (+495.95%)
Average
$2.17 (+331.07%)
Lowest
$0.50 (-0.68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Jefferies
Hold
Maintained
$0.50
-0.7%
08/27/2026
Michael Kupinski
Noble Financial
Buy
Maintained
$3.00
+495.9%
08/26/2026
Ben Hendrix
RBC Capital
Hold
Maintained
$3.00
+495.9%
08/25/2026
George Sutton
Craig-Hallum
Buy
Reiterated
-
-
05/06/2026
Patrick McCann, CFA
D. Boral Capital
Buy
Maintained
$5.00
+893.2%
03/19/2026
Last report
Aug 25, 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
-$0.17 / -$0.14
-25.93%miss
Revenue / Est. (USD)
321.65M / 353.44M
-8.99%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
328.81M
537.10M
430.93M
321.65M
Cost of goods sold
261.88M
308.23M
254.56M
218.24M
Cost of revenue
261.88M
308.23M
254.56M
218.24M
Research and development expenses
9.91M
9.60M
9.78M
9.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
97.77M
143.97M
130.67M
90.30M
Operating expense
107.68M
153.56M
140.45M
99.99M
Total operating expenses
369.56M
461.79M
395.00M
318.22M
Operating income
-40.75M
75.31M
35.93M
3.43M
Other non operating income
14.89M
19.26M
27.46M
-6.06M
EBT including unusual items
-37.66M
82.96M
44.12M
-13.13M
EBT excluding unusual items
-37.66M
82.96M
52.78M
-13.13M
Income tax expense
-7.20M
13.66M
3.93M
3.71M
Effective tax rate
19.13%
16.47%
8.90%
-28.27%
Other operating expenses
-
-
-
-
Net income
-30.46M
69.29M
40.20M
-16.84M
Net profit margin
-9.26%
12.90%
9.33%
-5.24%
Earnings per share
-0.24
0.29
0.04
-0.17
Interest and investment income
-
-
-
-
Interest expense
-11.81M
-11.61M
-10.60M
-10.50M
Net interest expenses
-11.81M
-11.61M
-10.60M
-10.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-38.55M
77.33M
38.02M
14.61M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps